Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients

Annals of Neurology

Volumn 76, Issue 4, 2014, Pages 620-624

  Hupf, Jonathan C ^c   Tadesse, Saba ^c   Mitsumoto, Hiroshi ^c   Valsecchi, Federica ^a   Manfredi, Giovanni ^a  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; BIOLOGICAL MARKER; MITOTRACKER GREEN FM; RHODAMINE; TETRAMETHYLRHODAMINE METHYL ESTER;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; DIAGNOSTIC USE; ENERGY METABOLISM; FIBROBLAST; HUMAN; MALE; METABOLISM; MIDDLE AGED; MITOCHONDRIAL MEMBRANE POTENTIAL; MOTOR NEURON DISEASE; PATHOLOGY; PHYSIOLOGY; SKIN;

ADULT; AGED; ALDEHYDES; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; ENERGY METABOLISM; FIBROBLASTS; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; MOTOR NEURON DISEASE; RHODAMINES; SKIN;

EID: 84907817312     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24244     Document Type: Article

References (19)

1. Turner MR, Bowser R, Bruijn L, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2013;14(suppl 1):19-32.
2. Lawton KA, Cudkowicz ME, Brown MV, et al. Biochemical alterations associated with ALS. Amyotrophic Lateral Scler 2012;13:110-118.
3. Faes L, Callewaert G. Mitochondrial dysfunction in familial amyotrophic lateral sclerosis. J Bioenerg Biomembr 2011;43:587-592.
4. Cozzolino M, Ferri A, Valle C, Carri MT. Mitochondria and ALS: implications from novel genes and pathways. Mol Cell Neurosci 2013;55:44-49.
5. Hervias I, Beal MF, Manfredi G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve 2006;33:598-608.
6. Vangipuram M, Ting D, Kim S, et al. Skin punch biopsy explant culture for derivation of primary human fibroblasts. J Vis Exp 2013(77):e3779.
7. Pendergrass W, Wolf N, Poot M. Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues. Cytometry A 2004;61:162-169.
8. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169:13-21.
9. Ono S, Toyokura Y, Mannen T, Ishibashi Y. "Delayed return phenomenon" in amyotrophic lateral sclerosis. Acta Neurol Scand 1988;77:102-107.
10. Suzuki M, Mikami H, Watanabe T, et al. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta Neurol Scand 2010;122:367-372.
11. Oketa Y, Higashida K, Fukasawa H, et al. Abundant FUS-immunoreactive pathology in the skin of sporadic amyotrophic lateral sclerosis. Acta Neurol Scand 2013;128:257-264.
12. Ishikawa H, Yasui K, Oketa Y, et al. Increased expression of valosin-containing protein in the skin of patients with amyotrophic lateral sclerosis. J Clin Neurosci 2012;19:522-526.
13. Fukazawa H, Tsukie T, Higashida K, et al. An immunohistochemical study of increased tumor necrosis factor-alpha in the skin of patients with amyotrophic lateral sclerosis. J Clin Neurosci 2013;20:1371-1376.
14. Ono S, Hu J, Shimizu N, et al. Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis. J Neurol Sci 2001;187:27-34.
15. Fang L, Huber-Abel F, Teuchert M, et al. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci 2009;285:62-66.
16. Kaplan A, Spiller KJ, Towne C, et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron 2014;81:333-348.
17. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321:1218-1221.
18. Meyer K, Ferraiuolo L, Miranda CJ, et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci U S A 2014;111:829-832.
19. Allen SP, Rajan S, Duffy L, et al. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiol Aging 2014;35:1499-1509.